anmeldenOMX Nordic 40
2.685,57
PKT
-21,68
PKT
-0,80
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu OMX Nordic 40-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 27.03.20 | Hennes Mauritz (H M, H&M) Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 27.03.20 | A.P. Moeller - Maersk A-S (B) Neutral | JP Morgan Chase & Co. | |
| 26.03.20 | Volvo (B) buy | Kepler Cheuvreux | |
| 26.03.20 | Hennes Mauritz (H M, H&M) Underperform | Bernstein Research | |
| 26.03.20 | Hennes Mauritz (H M, H&M) Neutral | UBS AG | |
| 25.03.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
| 24.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 23.03.20 | Novo Nordisk buy | UBS AG | |
| 23.03.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 20.03.20 | Volvo (B) Conviction Buy | Goldman Sachs Group Inc. | |
| 20.03.20 | Volvo (B) buy | Kepler Cheuvreux | |
| 20.03.20 | AstraZeneca buy | Deutsche Bank AG | |
| 19.03.20 | ABB (Asea Brown Boveri) Sector Perform | RBC Capital Markets | |
| 19.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 19.03.20 | Volvo (B) Neutral | UBS AG | |
| 18.03.20 | Novo Nordisk Outperform | Bernstein Research | |
| 17.03.20 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
| 17.03.20 | Volvo (B) buy | Kepler Cheuvreux | |
| 17.03.20 | Volvo (B) Conviction Buy | Goldman Sachs Group Inc. | |
| 17.03.20 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
| 17.03.20 | Novo Nordisk overweight | Barclays Capital | |
| 17.03.20 | AstraZeneca overweight | Barclays Capital | |
| 12.03.20 | Nokia buy | UBS AG | |
| 12.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 10.03.20 | Nokia Sell | Goldman Sachs Group Inc. | |
| 10.03.20 | Hennes Mauritz (H M, H&M) Neutral | Goldman Sachs Group Inc. | |
| 10.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 09.03.20 | AstraZeneca Sell | UBS AG | |
| 09.03.20 | AstraZeneca overweight | JP Morgan Chase & Co. | |
| 09.03.20 | ABB (Asea Brown Boveri) overweight | Barclays Capital | |
| 09.03.20 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
| 06.03.20 | Nokia Neutral | Credit Suisse Group | |
| 06.03.20 | AstraZeneca Sell | Goldman Sachs Group Inc. | |
| 06.03.20 | A.P. Moeller - Maersk A-S (B) kaufen | Jefferies & Company Inc. | |
| 05.03.20 | A.P. Moeller - Maersk A-S (B) Neutral | Goldman Sachs Group Inc. | |
| 05.03.20 | Volvo (B) Sell | UBS AG | |
| 04.03.20 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 03.03.20 | Nokia buy | Deutsche Bank AG | |
| 03.03.20 | Nokia Neutral | Credit Suisse Group | |
| 03.03.20 | ABB (Asea Brown Boveri) Underperform | Jefferies & Company Inc. |
